Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Daily News

STEMI Patients Far From PCI Centers Fare Well With Pharmacoinvasive Strategy

L.A. McKeown

October 05, 2016

News Daily News

No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX

Shelley Wood

October 03, 2016

News Daily News

Bivalirudin? Heparin? Physicians Are Divided Over Antithrombotic Choices for PCI in STEMI, Survey Shows

Yael L. Maxwell

September 15, 2016

News Daily News

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

L.A. McKeown

September 21, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Daily News

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Yael L. Maxwell

July 10, 2015

News Conference News ACC 2015

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

Todd Neale

March 17, 2015

News Daily News

Registry Data Suggest Net Clinical Benefit From Pretreating STEMI Patients With Clopidogrel

Todd Neale

February 05, 2015

News Daily News

NSTE-ACS Patients With Inflammation Gain the Most Kidney Protection From Statin Pretreatment

Yael L. Maxwell

December 15, 2014

News Daily News

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

L.A. McKeown

April 25, 2014

News Daily News

Transradial Approach May Balance Bleeding Benefits of Bivalirudin in Primary PCI

Jason Kahn

January 15, 2014

News Conference News ESC 2013

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

Yael L. Maxwell

September 01, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Conference News ACC 2013

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

L.A. McKeown

March 09, 2013

News Conference News ESC 2012

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

August 26, 2012

News Daily News

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Jason Kahn

July 17, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

Advertisement

STEMI Patients Far From PCI Centers Fare Well With Pharmacoinvasive Strategy

No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX

Bivalirudin? Heparin? Physicians Are Divided Over Antithrombotic Choices for PCI in STEMI, Survey Shows

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

Registry Data Suggest Net Clinical Benefit From Pretreating STEMI Patients With Clopidogrel

NSTE-ACS Patients With Inflammation Gain the Most Kidney Protection From Statin Pretreatment

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

Transradial Approach May Balance Bleeding Benefits of Bivalirudin in Primary PCI

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content